Cargando…
Novel clinical therapeutics targeting the epithelial to mesenchymal transition
The epithelial to mesenchymal transition (EMT) is implicated in many processes, ranging from tissue and organogenesis to cancer and metastatic spread. Understanding the key regulatory mechanisms and mediators within this process offers the opportunity to develop novel therapeutics with broad clinica...
Autores principales: | Kothari, Anai N, Mi, Zhiyong, Zapf, Matthew, Kuo, Paul C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4198571/ https://www.ncbi.nlm.nih.gov/pubmed/25343018 http://dx.doi.org/10.1186/s40169-014-0035-0 |
Ejemplares similares
-
Osteopontin—A Master Regulator of Epithelial-Mesenchymal Transition
por: Kothari, Anai N., et al.
Publicado: (2016) -
The novel epithelial-mesenchymal transition-related proteins and their therapeutic targets in cholangiocarcinoma: a narrative review
por: Kimawaha, Phongsaran, et al.
Publicado: (2023) -
Cytoskeletal Dynamics in Epithelial-Mesenchymal Transition: Insights into Therapeutic Targets for Cancer Metastasis
por: Datta, Arpita, et al.
Publicado: (2021) -
Epithelial–Mesenchymal Transition-Mediated Tumor Therapeutic Resistance
por: Xu, Zhimin, et al.
Publicado: (2022) -
Role of the Epithelial-Mesenchymal Transition in Bladder Cancer: From Prognosis to Therapeutic Target
por: Yun, Seok Joong, et al.
Publicado: (2013)